Rare but possible: clopidogrel-induced pancytopenia

We present the case of an 84-year-old female patient admitted to the Internal Medicine Ward for atypical chest pain and laboratory findings of severe pancytopenia. Past medical history was remarkable for an episode of myocardial infarction approximately 4 weeks prior to the current hospitalization...

Full description

Bibliographic Details
Main Authors: Pietro Bocchi, Pasquale Gianluca Giuri, Achiropita Bovino, Alessia Casola, Simona Detrenis, Marcello Bertorelli, Michele Meschi, Giancarlo Mangè
Format: Article
Language:English
Published: PAGEPress Publications 2023-10-01
Series:Italian Journal of Medicine
Subjects:
Online Access:https://italjmed.org/index.php/ijm/article/view/1660
_version_ 1827606697201369088
author Pietro Bocchi
Pasquale Gianluca Giuri
Achiropita Bovino
Alessia Casola
Simona Detrenis
Marcello Bertorelli
Michele Meschi
Giancarlo Mangè
author_facet Pietro Bocchi
Pasquale Gianluca Giuri
Achiropita Bovino
Alessia Casola
Simona Detrenis
Marcello Bertorelli
Michele Meschi
Giancarlo Mangè
author_sort Pietro Bocchi
collection DOAJ
description We present the case of an 84-year-old female patient admitted to the Internal Medicine Ward for atypical chest pain and laboratory findings of severe pancytopenia. Past medical history was remarkable for an episode of myocardial infarction approximately 4 weeks prior to the current hospitalization which had required angioplasty + drug-eluting stent and dual antiplatelet therapy with acetylsalicylic acid and clopidogrel. Some rare cases of clopidogrel-induced pancytopenia are described in scientific literature, therefore, after excluding infectious, vitamin deficiencies, and autoimmune causes, we modified the antiplatelet therapy by replacing clopidogrel with ticagrelor, obtaining complete leukocyte recovery within a few days. Since clopidogrel is an antiplatelet drug still used in clinical cardiological practice, the knowledge of this rare side effect may lead the clinician to suspect hematological toxicity which, if recognized promptly, may suggest modification of antiplatelet therapy and limit any possible infectious complications for the care of the patient.
first_indexed 2024-03-09T06:42:03Z
format Article
id doaj.art-24d7574ecc0442a0ab303978c54f14be
institution Directory Open Access Journal
issn 1877-9344
1877-9352
language English
last_indexed 2024-03-09T06:42:03Z
publishDate 2023-10-01
publisher PAGEPress Publications
record_format Article
series Italian Journal of Medicine
spelling doaj.art-24d7574ecc0442a0ab303978c54f14be2023-12-03T10:46:51ZengPAGEPress PublicationsItalian Journal of Medicine1877-93441877-93522023-10-0117310.4081/itjm.2023.1660Rare but possible: clopidogrel-induced pancytopeniaPietro Bocchi0Pasquale Gianluca Giuri1Achiropita Bovino2Alessia Casola3Simona Detrenis4Marcello Bertorelli5Michele Meschi6Giancarlo Mangè7Department of Internal Medicine, Vaio Hospital, Fidenza (PR)Department of Internal Medicine, Santa Maria Hospital, Borgo Val di Taro (PR)Department of Internal Medicine, Vaio Hospital, Fidenza (PR)Department of Internal Medicine, Vaio Hospital, Fidenza (PR)Department of Internal Medicine, Santa Maria Hospital, Borgo Val di Taro (PR)Department of Clinical Cardiology, Cardiologic Rehabilitation and High Care Ward, Santa Maria Hospital, Borgo Val di Taro (PR)Department of Internal Medicine, Vaio Hospital, Fidenza (PR)Department of Internal Medicine, Vaio Hospital, Fidenza (PR) We present the case of an 84-year-old female patient admitted to the Internal Medicine Ward for atypical chest pain and laboratory findings of severe pancytopenia. Past medical history was remarkable for an episode of myocardial infarction approximately 4 weeks prior to the current hospitalization which had required angioplasty + drug-eluting stent and dual antiplatelet therapy with acetylsalicylic acid and clopidogrel. Some rare cases of clopidogrel-induced pancytopenia are described in scientific literature, therefore, after excluding infectious, vitamin deficiencies, and autoimmune causes, we modified the antiplatelet therapy by replacing clopidogrel with ticagrelor, obtaining complete leukocyte recovery within a few days. Since clopidogrel is an antiplatelet drug still used in clinical cardiological practice, the knowledge of this rare side effect may lead the clinician to suspect hematological toxicity which, if recognized promptly, may suggest modification of antiplatelet therapy and limit any possible infectious complications for the care of the patient. https://italjmed.org/index.php/ijm/article/view/1660Clopidogrelneutropeniamyocardial infarctionadverse drug reaction
spellingShingle Pietro Bocchi
Pasquale Gianluca Giuri
Achiropita Bovino
Alessia Casola
Simona Detrenis
Marcello Bertorelli
Michele Meschi
Giancarlo Mangè
Rare but possible: clopidogrel-induced pancytopenia
Italian Journal of Medicine
Clopidogrel
neutropenia
myocardial infarction
adverse drug reaction
title Rare but possible: clopidogrel-induced pancytopenia
title_full Rare but possible: clopidogrel-induced pancytopenia
title_fullStr Rare but possible: clopidogrel-induced pancytopenia
title_full_unstemmed Rare but possible: clopidogrel-induced pancytopenia
title_short Rare but possible: clopidogrel-induced pancytopenia
title_sort rare but possible clopidogrel induced pancytopenia
topic Clopidogrel
neutropenia
myocardial infarction
adverse drug reaction
url https://italjmed.org/index.php/ijm/article/view/1660
work_keys_str_mv AT pietrobocchi rarebutpossibleclopidogrelinducedpancytopenia
AT pasqualegianlucagiuri rarebutpossibleclopidogrelinducedpancytopenia
AT achiropitabovino rarebutpossibleclopidogrelinducedpancytopenia
AT alessiacasola rarebutpossibleclopidogrelinducedpancytopenia
AT simonadetrenis rarebutpossibleclopidogrelinducedpancytopenia
AT marcellobertorelli rarebutpossibleclopidogrelinducedpancytopenia
AT michelemeschi rarebutpossibleclopidogrelinducedpancytopenia
AT giancarlomange rarebutpossibleclopidogrelinducedpancytopenia